[HTML][HTML] Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions

H Parvaresh, G Roozitalab, F Golandam, P Behzadi… - Biomedicines, 2024 - mdpi.com
Background and Objective: This review comprehensively explores the intricate landscape of
anaplastic lymphoma kinase (ALK), focusing specifically on its pivotal role in non-small cell …

[HTML][HTML] New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations

I Attili, C Corvaja, G Spitaleri, E Del Signore… - Cancers, 2023 - mdpi.com
Simple Summary This manuscript focuses on improving the treatment of non-small cell lung
cancer, with actionable gene alterations. The aim is to understand how the treatment with …

[HTML][HTML] Lung cancer biomarkers: Raising the clinical value of the classical and the new ones

S Holdenrieder, HH van Rossum… - Tumor …, 2024 - content.iospress.com
Blood-based diagnostics for lung cancer support the diagnosis, estimation of prognosis,
prediction, and monitoring of therapy response in lung cancer patients. The clinical utility of …

[HTML][HTML] Associations between immune cell phenotypes and lung cancer subtypes: insights from mendelian randomization analysis

JM Zheng, CX Lou, YL Huang, WT Song, YC Luo… - BMC Pulmonary …, 2024 - Springer
Introduction Lung cancer is a common malignant tumor, and different types of immune cells
may have different effects on the occurrence and development of lung cancer subtypes …

[HTML][HTML] Unravelling the Role of Key Genes in Oral Cancer Progression: A Comprehensive Review

R Suresh, A Krishnan - Oral Oncology Reports, 2024 - Elsevier
Conclusion To summarize, oral cancer has a large global impact as evidenced by its
prevalence in the incident rates particularly in the Indian subcontinent. The pathogenesis of …